Gapping up
In reaction to earnings/guidance:
- MS +2.4%, GS +2.1%, TSM +1.5%, USB +1.3%, STT +1.2%, RAD +0.9%, UNH +0.6%
Other news:
- VALN +20.6% (receives conditional marketing authorization from UK MHRA for its inactivated COVID-19 vaccine)
- TWTR +6.8% (confirms receipt of unsolicited non-binding proposal from Elon Musk; will carefully review the proposal)
- SMPL +4.3% (approves the addition of $50 mln to existing stock repurchase program)
- AGX +2.7% (increases existing share repurchase program to $75 mln from $50 mln)
- CWK +2.4% (acquisition of Sheffield Property and Sheffield Asset Management)
- RYAM +2.4% (comments on letter from Chatham Asset Management)
- INMB +1.6% (dosed first patient in Phase 2 trial of XPro1595)
- SVM +1.6% (reports op results; reiterates its Fiscal 2023 production guidance)
- ANSS +1.4% (agreed to acquire OnScale)
- ROL +1.1% (acquired Norfolk UK-based NBC Environment)
Analyst comments:
- CXW +4% (upgraded to Outperform from Neutral at Wedbush)
- RPRX +1.8% (upgraded to Overweight from Neutral at JP Morgan)
- DAL +1.2% (upgraded to Overweight from Equal Weight at Barclays)